Pancreatic Cancer Research

ResearcherCardiff UniversityActive in the last 2 years

Wen G. Jiang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-3283-1111; OpenAlex author ID A5105286128. Sources: OpenAlex.

Their work

Papers
8 (first author 0, last author 4)
Trials
0
Grants
0
Labs led
1
Collaborators
14
Papers, trials and grants by year

2016: 1 paper · 2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: 3 papers · 2022: none · 2023: none · 2024: 2 papers · 2025: 1 paper

Papers 8

  1. Noggin Promotes Cell Proliferation Through Up-regulating EGFR/HER2 in Pancreatic Cancer Cells. Co-author DOI 10.21873/cgp.20522↗
  2. EPLIN, a prospective oncogenic molecule with contribution to growth, migration and drug resistance in pancreatic cancer. Last author DOI 10.1038/s41598-024-81485-w↗
  3. Implication of Capillary Morphogenesis Gene 2 (CMG2) in the Disease Progression and Peritoneal Metastasis of Pancreatic Cancer. Co-author DOI 10.3390/cancers16162893↗
  4. Expression of Death Associated Proteins DAP1 and DAP3 in Human Pancreatic Cancer. Last author DOI 10.21873/anticanres.15010↗
  5. Reduced kinase D‑interacting substrate of 220 kDa (Kidins220) in pancreatic cancer promotes EGFR/ERK signalling and disease progression. Co-author DOI 10.3892/ijo.2021.5214↗
  6. Activated leukocyte cell adhesion molecule (ALCAM)/CD166 in pancreatic cancer, a pivotal link to clinical outcome and vascular embolism. Last author PMID 35018233↗
  7. Psoriasin promotes invasion, aggregation and survival of pancreatic cancer cells; association with disease progression. Co-author DOI 10.3892/ijo.2017.3953↗
  8. IL24 and its Receptors Regulate Growth and Migration of Pancreatic Cancer Cells and Are Potential Biomarkers for IL24 Molecular Therapy. Last author PMID 26977011↗

Closest collaborators

The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Chunyi Hao · 8 shared papers, 2016–2025 · strength 1.20
  2. Lin Ye · 5 shared papers, 2016–2024 · strength 0.57
  3. Bilal A. Al-Sarireh · 3 shared papers, 2017–2024 · strength 0.36
  4. Laijian Sui · 2 shared papers, 2021–2024 · strength 0.34
  5. Jiafu Ji · 3 shared papers, 2016–2021 · strength 0.30
  6. Lin Ye · 1 shared paper, 2025 · strength 0.28
  7. Ming Liu · 1 shared paper, 2025 · strength 0.28
  8. Yiming Yang · 2 shared papers, 2021 · strength 0.28
  9. Jianyuan Zeng · 1 shared paper, 2024 · strength 0.22
  10. Ziqian Fang · 1 shared paper, 2024 · strength 0.19
  11. Shuo Cai · 2 shared papers, 2017–2021 · strength 0.17
  12. Yongning Jia · 1 shared paper, 2016 · strength 0.07
  13. Gang Chen · 1 shared paper, 2017 · strength 0.06
  14. Ying Liu · 1 shared paper, 2017 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.